1Eriksdotter Jonhagen M, Nordbeg A, Amberla K, et al. Intracerebroventricular infusion of nerve growth factor in three patients wiih Alzheimer's disease . Dement Geriatr Cogn Disord,1998,9(5):246- 257.
2Hock C, Heese K, Hulette C, et al. Region - specific neurotrophin inbanlances in Alzheimer disease:decreased levels of brain- derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol,2000,57(6):846-851.
3Elias KA,Cronin MJ, Stewart TA, et al. Peripheral neuropathy in transgenic diabetic mice: restoration of C - biber gunction with human recombinant nerve growth factor. Diabetes,1998, 47(10):1637 - 1642.
4Rask CA. Biological action of nerve growth factor in the peripheral nervous system. Eur Neurol, 1999,41 (1): 14- 19.
6Freeman R. Human studies of recombbinant human verve growth factor and diabetic perepheral neuropathy. Eur Neurol,1999, 41(1):20-26.
7Apfel SC, Kessler LA, Adomato BT, et al. Recombinant human verve growth factor in the treatment of diabetic ployneuropathy. Neurology, 1998,51(3):695-702.
8Hayakawa K, Itoh T, Niwa H,et al.NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGFtreatment schedule: in vitro study of adult rat sympathetic ganglion explants.Brain Res, 1998,794(2) :313 - 319.
9Shah SB,Gladstone HB,Williams H,et al.An extended study: protective efects of nerve growth factor in neomycin- induced auditory neural degeneration. Am J 0tol,1995,16(3):310-314.
10You L, Krusc FE,Volckcr HE.Neurotrophic factors in human comea. Invest Ophthalmol Vis Sci,2000,41(3):692- 702.
